Testing times! Choosing Wisely when it comes to monitoring type 2 diabetes-Reference-Cited by-同舟云学术

Testing times! Choosing Wisely when it comes to monitoring type 2 diabetes

Published:2015-11 Issue:9 Volume:203 Page:354-356
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Speight Jane¹²,Browne Jessica L¹²,Furler John S³

Affiliation:

1. Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, VIC

2. Deakin University, Melbourne, VIC

3. University of Melbourne, Melbourne, VIC

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja15.00639

Reference10 articles.

1. The cost of diabetes in adults in Australia

2. Choosing Wisely Australia and Royal Australian College of General Practitioners.5 things clinicians and consumers should question.2015.http://www.choosingwisely.org.au/getmedia/cafaec2c‐d407‐4997‐b1a4‐1d5dccf0f393/RACGP‐Choosing‐Wisely‐recommendations‐270415.pdf.aspx(accessed Jun 2015).

3. Self‐monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin;Malanda UL;Cochrane Database Syst Rev,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychosocial and Behavioural Aspects of Diabetes;Textbook of Diabetes;2024-01-12

2. The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis;Frontiers in Clinical Diabetes and Healthcare;2023-04-20

3. Practise of self-monitoring of blood glucose among pregnant women with gestational diabetes mellitus: A review;Indian Journal of Obstetrics and Gynecology Research;2023-02-15

4. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes;Journal of the American Pharmacists Association;2021-11

5. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial;The Lancet Diabetes & Endocrinology;2020-01